Clinical trial matching means finding patients who fit the rules to join a clinical trial. Usually, this takes a long time because people have to check patient records by hand. Many trials don’t reach their enrollment goals because it is hard and slow to find the right patients. AI can help by looking at lots of patient data much faster and more accurately.
For example, Tempus uses AI to check many types of real-world data. This includes information about genes, health history, molecules, and behavior. Their system connects with about 65% of Academic Medical Centers in the US and helps over half of US cancer doctors with tests and trial matching. By studying complex patient data, AI can see which trials a patient might fit, helping get them into trials more quickly.
This method has already found over 30,000 possible trial participants within the Tempus network. Accurate matching helps patients enter trials faster and get treatments that fit their condition. AI-based matching helps both patients and healthcare workers by making trial access easier and personalizing treatments.
Machine learning tools and natural language processing (NLP) also help with matching. NLP can pull out rules for who qualifies from unorganized medical records like doctor’s notes. This improves the accuracy without only using fixed data. This is important because a lot of patient info is written in free text in electronic health records (EHRs).
Finding and signing up patients is one of the biggest problems in running clinical trials. In the UK, only 31% of cancer trials meet their recruitment goals without AI help. In the US, difficulty with enrollment causes delays and extra costs for drug development. AI can quickly check patient data from different hospitals to find the right patients for trials.
AI can also use data from social media, wearable devices, and health apps to find and reach out to possible trial participants. Predictive analytics let AI spot patients who may benefit from a trial or meet special needs. This speeds up recruitment.
This reduces time and money spent on screening and recruiting while improving success rates. AI can also find groups of patients to create better treatment groups. Adaptive trials use AI to change trial steps in real time based on new data, helping keep patients involved and improving enrollment.
AI links patients to the best clinical trials using detailed data. This helps improve treatment results. Precision medicine focuses on finding patient traits like gene markers to make treatments fit better. AI can quickly process many types of information, making it a key tool.
Tempus’ AI supports cancer drug development and custom treatment plans by combining molecular data with clinical trial matching. Almost all of the top 20 cancer drug companies in the US work with Tempus to use AI for choosing the best patients for research and treatment.
Trials with better matching and enrollment usually have better effectiveness, fewer side effects, and clearer results about the drug’s benefits and risks. AI also helps predict how patients will do, improves trial design, and picks the best number of participants. This leads to more reliable results that improve patient care.
Research shows AI can help find biomarkers. Biomarkers are important for immunotherapy trials because they show which patients might respond well to certain drugs. For example, the Immune Profile Score (IPS) made by Tempus helps pick patients who could benefit from specific immune treatments, improving trial speed and precision.
Besides patient matching, AI also helps by automating many tasks in clinical trials, especially front-office and admin jobs in healthcare. This is important for hospital leaders and IT managers who want to make trials run better and lower staff work.
AI can handle many patient calls about trial questions, screening, appointments, and other details. This cuts down wait times and lets patients talk with trial staff faster. It also helps with scheduling and follow-up messages, keeping participants informed.
In medical offices, AI tools can help with billing for trial visits, track rules to follow, and manage data sent to sponsors. Smart workflows cut human mistakes and reduce delays or lost info.
AI systems also help collect data from EHRs, wearables, and devices in real time. This improves data correctness and cuts down repeated work so doctors and trial teams can focus more on patients and science.
Some groups, like Tempus, have started putting AI into electronic health records and trial operations. This means less manual work for doctors and staff and faster, more accurate patient matching and enrollment.
Even with many benefits, using AI in trial matching and management has challenges. One big issue is making sure the data AI uses is good and available. Health groups must keep high standards for collecting, processing, and combining data to get correct AI results.
Following rules and protecting patient privacy are also very important. AI handles private patient data, so it must follow laws like HIPAA in the US. It is also important to be clear about how AI makes decisions and respect patient consent.
Training healthcare staff and leaders on AI tools is important for success. Knowing what AI can and cannot do helps teams use the systems well while still providing personal care to patients.
Recent studies show AI’s real impact on trial efficiency and patient results. The MASAI trial found that AI helped increase cancer detection rates by almost 30%. This shows AI’s use goes beyond trial matching and includes diagnosis and treatment checks.
The Cleveland Clinic reported better trial enrollment using AI tools that make patient access and matching faster, which cuts down trial start times.
Tempus works with drug companies like BioNTech and AstraZeneca to use AI data analysis to find new treatment targets and improve cancer therapies. AI can study large amounts of molecular and clinical data, helping develop precise medicine approaches important in cancer care.
Hospital administrators, clinic owners, and IT managers in the US should think about AI’s role in clinical and management areas of trials. AI improves patient recruitment and enrollment. It also helps with data handling, following rules, and patient communication.
Using AI can speed up clinic work by automating screening, allowing faster patient referrals to trials, and lowering paperwork for healthcare teams. AI-based trial matching supports patient-focused care by matching treatments to patient profiles and improving health results.
Choosing AI systems that work well with current electronic health record software and offering staff training will get the most from AI. Also, health leaders must watch data security carefully and keep patients informed about how their data is used.
AI is not just an idea for the future but is already helping clinical trial matching, enrollment, and treatment results in the US. Its use in cancer and other treatment areas shows promise for making drug development faster and improving research quality.
Hospitals and clinics that use AI technology can expect better workflow efficiency and patient satisfaction. They also help produce better medical research that benefits the wider health system.
By understanding what AI can do, the chances it offers, and its challenges, healthcare leaders and IT managers can prepare their organizations to handle current trial and operational needs and get ready for future improvements in clinical trials.
AI-supported clinical trial matching is becoming more data-focused and patient-centered in the US. This helps patients get faster and better treatments. Medical groups that invest in these technologies are positioning themselves well in the changing healthcare world.
AI-enabled precision medicine uses artificial intelligence to enhance patient care by accelerating the discovery of new treatment targets, predicting treatment effectiveness, and identifying suitable clinical trials, ultimately allowing for earlier diagnoses of various diseases.
AI can help healthcare providers make more informed treatment decisions by analyzing large volumes of data, identifying care gaps, and providing tailored insights that lead to better patient outcomes.
AI can efficiently handle high call volumes, reducing wait times for patients, streamlining appointment scheduling, and improving overall patient engagement, which enhances the patient experience.
AI assists in clinical trial matching by analyzing patient data and identifying individuals who may qualify for specific trials, increasing the chances of successful enrollment and outcomes.
Tempus partners with over 95% of the top 20 pharmaceutical companies in oncology by providing molecular profiling and data-driven insights to enhance drug development and treatment personalization.
Tempus utilizes multimodal real-world data, including genomic, clinical, and behavioral data, helping to provide comprehensive insights into patient care and treatment options.
AI improves patient care by enabling high-quality testing, efficient trial matching, and deep analysis of research data, all contributing to better patient outcomes.
Olivia is an AI-enabled personal health concierge app designed for patients and caregivers to help them manage, organize, and proactively control their health data.
Tempus launched a collaboration with BioNTech for real-world data usage and received FDA clearance for its AI-based Tempus ECG-AF device to identify patients at risk of atrial fibrillation.
AI accelerates the identification of novel therapeutic targets, enhancing the speed and accuracy of treatment development in precision medicine, which is critical in improving patient outcomes in complex diseases.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
